Phenytoin-induced toxic epidermal necrolysis: Review and recommendations
- PMID: 27651708
- PMCID: PMC5020771
- DOI: 10.4103/0976-500X.189662
Phenytoin-induced toxic epidermal necrolysis: Review and recommendations
Abstract
Toxic epidermal necrolysis (TEN) is a serious, life-threatening skin reaction characterized by severe exfoliation and destruction of the epidermis of the skin. In most TEN cases, drugs are believed to be the causative agent; antipsychotics, antiepileptics, and other medications such as sulfonamides are among the most common causes of drug-induced TEN. Phenytoin, a commonly prescribed medication for seizure, was found to cause TEN. Evidence-based treatment guidelines are lacking, so the best strategy is to identify and avoid potential risk factors and to provide intensive supportive care. The aim of this literature review is to focus on phenytoin-induced TEN, to explore the risk factors, and to highlight the possible treatment options once phenytoin-induced TEN is confirmed.
Keywords: Adverse drug reaction; Lyell's syndrome; Stevens–Johnson syndrome; diphenylhydantoin; phenytoin toxicity; toxic epidermal necrolysis.
Similar articles
-
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008. Drug Saf. 2005. PMID: 16180941
-
Toxic epidermal necrolysis (Lyell's disease).Burns. 2010 Mar;36(2):152-63. doi: 10.1016/j.burns.2009.06.213. Epub 2009 Sep 18. Burns. 2010. PMID: 19766401 Review.
-
[Stevens-Johnson syndrome, toxic epidermal necrolysis and phenytoin. Factors linked to a higher risk].Rev Neurol. 2004 Jun 1-15;38(11):1056-60. Rev Neurol. 2004. PMID: 15202085 Review. Spanish.
-
[Stevens-Johnson Syndrom and Toxic Epidermal Necrolysis--based on literature].Przegl Lek. 2015;72(1):35-7. Przegl Lek. 2015. PMID: 26076576 Review. Polish.
-
Toxic epidermal necrolysis (TEN) Lyell's syndrome.J Dermatolog Treat. 2005;16(5-6):278-86. doi: 10.1080/09546630500375684. J Dermatolog Treat. 2005. PMID: 16428146 Review.
Cited by
-
Immunological Mechanisms in Cutaneous Adverse Drug Reactions.Biomol Ther (Seoul). 2024 Jan 1;32(1):1-12. doi: 10.4062/biomolther.2023.170. Biomol Ther (Seoul). 2024. PMID: 38148549 Free PMC article. Review.
-
A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.Cureus. 2023 Apr 14;15(4):e37596. doi: 10.7759/cureus.37596. eCollection 2023 Apr. Cureus. 2023. PMID: 37197134 Free PMC article.
-
Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics.Front Pharmacol. 2022 Apr 20;13:832048. doi: 10.3389/fphar.2022.832048. eCollection 2022. Front Pharmacol. 2022. PMID: 35517811 Free PMC article. Review.
-
Toxicological evaluation of convulsant and anticonvulsant drugs in human induced pluripotent stem cell-derived cortical neuronal networks using an MEA system.Sci Rep. 2018 Jul 10;8(1):10416. doi: 10.1038/s41598-018-28835-7. Sci Rep. 2018. PMID: 29991696 Free PMC article.
References
-
- Lyell A. Toxic epidermal necrolysis: An eruption resembling scalding of the skin. Br J Dermatol. 1956;68:355–61. - PubMed
-
- Prashant Tiwari, Rajnikant Panik, Arin Bhattacharya, Dheeraj Ahirwar, Anish Chandy. Toxic epidermal necrolysis: An update. Asian Pac J Trop Dis. 2013;3:85–92.
-
- Parrillo SJ. Stevens-Johnson syndrome and toxic epidermal necrolysis. Curr Allergy Asthma Rep. 2007;7:243–7. - PubMed
-
- Rappersberger K, Foedinger D. Treatment of erythema multiforme, Stevens-Johnsons syndrome, and toxic epidermal necrolysis. Dermatol Ther. 2002;15:397–408.
-
- Kardaun SH, Jonkman MF. Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol. 2007;87:144–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources